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Introduction
It is thought that a vicious circle prevails in chronic respiratory tract inflammatory diseases such as chronic sinusitis and diffuses panbronchiolitis, involving infection by pathogenic microbes on the one hand and the body's immune response on the other. Pathogens disrupt the local defense mechanisms and thus become established locally, and this induces an immune response on the part of the host. Especially in the case of inflammation having IL-8 and neutrophils as key elements, the local defense mechanisms are further disrupted by esterases and active enzymes, the clearance of the pathogens is interfered with, and a vicious circle results [1] .
Fourteen-member lactone-ring macrolide antimicrobial agents are used as immunomodulators in the treatment of such chronic respiratory tract inflammatory diseases as chronic sinusitis, sinobronchial syndrome and diffuse panbronchiolitis, etc., and they have been reported to be useful in this application [2] [3] [4] [5] [6] . It is said that low-dose long-term chemotherapy of macrolides for these chronic respiratory tract inflammatory diseases stops the excessive immune response of the host and makes it possible to eliminate the vicious circle. There have been multiple reports that the underlying mechanism of macrolides in this role is that they inhibit the production of IL-8 and various other inflammatory cytokines [7] [8] [9] [10] [11] , while it has also been reported that macrolides show inhibitory effects at the levels of mRNA and NF-κB and AP-1 transcription factors [12] [13] [14] [15] [16] [17] . Iino et al. demonstrated that the expression of a costimulator of antigen-presenting cells was inhibited by macrolides [18, 19] . In addition, Asano et al. showed that macrolides specifically inhibit Th2 cytokines [20, 21] . However, there remain many facets of the action mechanism underlying the anti-inflammatory effects of macrolides that are not fully understood.
Dendritic cells (DCs) are distributed in many tissues of the body, and it is known that they play an important role in inducing immune responses by carrying out antigen presentation to T cells. In addition, in recent years it has been shown that DCs are also involved in immunologic tolerance, and attention has thus been given to the aspect of DCs as immunoregulatory cells. It has also recently been shown that culture of CD14 + human peripheral blood monocytes in the presence of GM-SF and IL-4 for about 7 days is capable of inducing differentiation of DCs, and research on DCs themselves has become vigorous [22] . Nevertheless, there have still been few reports of studies of the effects of macrolides on human DCs.
Haemophilus influenzae is an important bacterial causative organism of chronic airway inflammatory diseases. One of the outer membrane proteins of this bacterium is the P6 protein, which is a commonly shared antigen of all Haemophilus influenzae strains. P6 is a target antigen for induction of infection-preventing antibodies, and it has also received much attention as the target of vaccine therapy [23] [24] [25] [26] .
The objective of the present study was to investigate the effects of macrolides on such antigen-specific immune responses of CD4+ T cells as their proliferative response and their cytokines production (IL-8 and Th1/2 cytokines). These investigations were carried out using DCs generated from peripheral blood and the P6 outer membrane protein of Haemophilus influenzae. 5x10 3 /well, and then the test drugs were added to the wells in three concentrations of 10.0 μg/mL, 1.0 μg/mL and 0.1 μg/mL. P6 protein was then added to each well at 10.0 μg/mL, and the plates were incubated in RPMI1640 supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin 2x10 -5 2ME and 10% heat-inactivated human AB serum (SIGMA-ALDRICH, For the ELISA and the determination of the proliferative response, the wells for each condition were prepared in triplicate, and the mean values were determined. The graphs show the error bars for the mean±1 SD of the specimens from the five donors. Paired two group t-test was used to compare mean values. In addition, for investigation of the effects of the drugs on the DCs, only
DCs were incubated with one of the drugs for the first 48 hr, after which the drug was eliminated, and then CD4+ T cells were added and investigated in the same manner as above. The IL-4 concentration are presented in Fig. 3 . It is seen that stimulation with P6 protein alone resulted in almost no IL-4 production. The concentration of IL-4 was significantly increased by the presence of clarithromycin at 10 μg/mL and also by prednisolone at 10 μg/mL (p<0.05).
Results

Figure
Roxithromycin did not induce a statistically significant change in the IL-4 production, but there was a tendency for IL-4 to be increased at each roxithromycin concentration. production to a mean concentration of 390.7 pg/mL. Both roxithromycin and clarithromycin at 10 μg/mL inhibited the production of IL-5 such that its concentration was below the limit of detection.
Prednisolone also suppressed IL-5 production below the limit of detection at each of the concentrations at which it was added. The drugs were added to cultures of only DCs, as well, and then the proliferative response ( Fig. 6 ) and the productions of IFN-γ ( Fig. 7) and IL-8 ( Fig. 8) were investigated. No statistically significant differences were observed, but as with the above results, there were tendencies for the proliferative response and the productions of IFN-γ and IL-8 to be inhibited by the added drugs in a dose-dependent manner.
Discussion
Fourteen-member lactone-ring macrolide antimicrobial agents are employed in the treatment of chronic respiratory tract inflammatory diseases since they show immunomodulating activity, and their usefulness in that application has been reported [2] [3] [4] [5] [6] . With regard to the underlying mechanism of macrolides in this role, they have been reported to inhibit the production of mRNA for IL-8 and various other inflammatory cytokines [7] [8] [9] [10] [11] , and there have also been reports that macrolides show inhibitory effects at the levels of the NF-κB and AP-1 transcription factors [12] [13] [14] [15] [16] [17] . There have been reports of studies of the effects of macrolides on Langerhans cells, epithelial cells and fibroblasts, but to date there have been few reports of studies involving the effects of these drugs on induced DCs. In addition, although the effects of macrolides on the immune responses of CD4+ T cells to nonspecific stimuli such as TCR (anti-CD3) and LPS have been reported [21] , few studies have been carried out in relation to the immune response to actual cell components of causative bacteria. In consideration of this background, we designed the present experiments using DCs and the P6 protein to investigate the effects of macrolides on the antigen-specific immune responses of CD4+ T cells.
The macrolides we used were roxithromycin and clarithromycin, two so-called new macrolides. The new macrolides are said to have immunomodulatory activity [2] [3] [4] [5] [6] . We did not use erythromycin in this study, but it can be thought that it will be necessary to compare various drugs (roxithromycin, clarithromycin and other macrolides) with erythromycin in future studies. In addition, we selected prednisolone as a control drug showing inhibition of immune responses [7] .
The concentrations of the macrolides and prednisolone that were used in this study were selected in consideration of the concentrations they show in the blood when administered orally to human patients. The usual clinical doses of these macrolides in low does long-term chemotherapy are 150 mg in the case of roxithromycin and 200 mg for clarithromycin. In addition, the maximum plasma concentration (Cmax) after oral administration of 150 mg of roxithromycin is 6.8 μg/mL [30] , while that after clarithromycin 200 mg per os (po) is 1.16 μg/mL [31] . Accordingly, we selected three concentrations for use in this study: 0.1 μg/mL, 1.0 μg/mL and 10 μg/mL, for both roxithromycin and clarithromycin. Similarly, prednisolone administered po in a 5-mg dose yields a Cmax of 0.105 μg/mL, while a 50-mg po dose shows a Cmax of 0.66 μg/mL [32] . We thus decided to use prednisolone at the same three concentration levels as the two macrolides.
As an index of the immune response of CD4+ T cells, we evaluated the proliferative response by measuring the incorporation of [ 3 H]-thymidine into the cells. Both roxithromycin and clarithromycin at concentrations of 1.0 μg/mL and higher showed statistically significant inhibition of the proliferative response in comparison with when no macrolide was added to the cell cultures.
As noted above, the Cmax of each drug was higher than 1.0 μg/mL, and it can be surmised that these drugs would show a sufficient inhibitory effect even when employed in a dose that is actually used.
In earlier studies carried out by our group, we demonstrated that when using DCs and stimulating CD4+ T cells with P6 protein, the T cells preferentially produced IFN-γ. Accordingly, in the present study we investigated the effects of macrolides on cytokine production by measuring the T cells' and DCs' IFN-γ production using an ELISA technique. Roxithromycin was found to inhibit IFN-γ production at each of its added concentrations, whereas clarithromycin showed statistically significant inhibition of IFN-γ production only when added to the cell culture at a concentration of 10 μg/mL. The data for clarithromycin showed considerable scattering, resulting in statistically significant inhibition being found only for the 10-μg/mL concentration, but as in the case of the proliferative response both of the macrolides showed dose-dependent inhibition of IFN-γ production. In addition, it has been reported that macrolides also affect the Th1/2 balance, and for this reason we assayed the productions of IL-4 and IL-5 by T cells as Th2 cytokines [20, 21] . In our earlier studies using DCs and stimulating CD4+ T cells with P6 protein, we found that almost no IL-4 was produced, while there was slight production of IL-5. In the present study, IL-5
showed a tendency to be inhibited by both roxithromycin and clarithromycin, whereas IL-4 production conversely showed a tendency to be increased. It might be thought that this increase in IL-4 can be explained as a relative acceleration of the Th2 response due to inhibition of the Th1 response. However, IL-5 is also a Th2 cytokine, and its production was inhibited, and this difference in the effects on IL-4 and IL-5 needs to be investigated in future studies. This phenomenon may not be changing the balance of Th1/Th2, and may be showing the immunomodulatory effects which became superfluous.
IL-8 is a cytokine that is produced by monocyte and macrophage lineages and is involved in the migration of neutrophils and T cells [11, 12, 15, 16] . Accordingly, under the conditions of our present studies, it can be surmised that IL-8 is produced mainly by the DCs. Both roxithromycin and clarithromycin showed concentration-dependent inhibition of the production of IL-8, each with statistical significance at 10 μg/mL. Therefore, it can be surmised that macrolides possess activity by which they significantly inhibit the production of IL-8 by DCs. As was noted in our introductory comments to this paper, it can be thought that this inhibition of IL-8 production is extremely important from the viewpoint of disrupting the vicious circle considered to prevail in chronic respiratory tract inflammatory diseases.
These studies described above were carried out using our experimental system in which DCs and T cells are incubated in mixed culture and both are exposed to the actions of macrolides.
As a control, we also cultured DCs alone and exposed them to the drugs, while conversely culturing T cells without adding any drugs to the cultures. No statistically significant differences were found between these two sets of conditions, although there were similar tendencies for inhibition of the immune response (i.e., proliferative response, IFN-γ and IL-8 production). These results indicate that macrolides also exert immunomodulatory effects directly on DCs, as well.
The following three conclusions can be drawn on the basis of the experimental results production with P6 protein stimulation without any drug was 390.7 pg/ml. With 10-μg/mL roxithromycin and 10-μg/mL clarithromycin, the production of IL-5 was suppressed, and it was below the limit of detection. In the presence of prednisolone, production of IL-5 was suppressed at each concentration, and it was below the limit of detection. production with P6 protein stimulation without any drug was 2818.9 pg/mL. With 10 μg/mL clarithromycin and 10 μg/mL roxithromycin, production of IL-8 was reduced in a concentration-dependent manner, with statistical significance (p<0.05). In presence of prednisolone (10 μg/mL and 1.0 μg/mL), production of IL-8 was reduced in a concentration-dependent manner (p<0.05). protein, was analyzed (only the dendritic cells were exposed to drugs). The CPM average with P6 protein but without any drug was 4793.7. The proliferative response was suppressed in the presence of DCs, which had been exposed to clarithromycin and roxithromycin, compared to without any drug; this suppression was concentration-dependent. These proliferative responses (CPM) were suppressed in dose dependent manner (n.s.), respectively. 
